Pharmacokinetic properties of the beta-adrenergic receptor blocking drugs

Factors affecting free (unbound) lignocaine concentration in suspected acute myocardial infarction.

British journal of clinical pharmacology·1989

Effect of cetamolol on epinephrine-induced hypokalemia.

Journal of clinical pharmacology·1988

In support of cardiac chronotropic beta 2 adrenoceptors.

The American journal of cardiology·1986

The effect of etodolac administration on renal function in patients with arthritis.

Journal of clinical pharmacology·1986

A free lignocaine index as a guide to unbound drug concentration.

British journal of clinical pharmacology·1985

Determinants of plasma alpha 1-acid glycoprotein (AAG) concentrations in health.

British journal of clinical pharmacology·1985

Antibiotic-Refractory Chronic Pouchitis After Ileal Pouch-Anal Anastomosis: Current and Emerging Therapeutic Strategies.

Drugs·2026

Current and Emerging Biomarkers and Surrogate Endpoints in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).

Drugs·2026

Doravirine/Islatravir: First Approval.

Drugs·2026

Anbenitamab: First Approval.

Drugs·2026

GLP-1 Receptor Agonists and Musculoskeletal Outcomes: A Systematic Literature Review and Meta-Analysis.

Drugs·2026

Safety Profile of the Non-steroidal Anti-inflammatory Drug Celecoxib in the Short-Term Management of Acute Non-cancer Pain: A Systematic Review with Meta-analysis of Randomised Controlled Trials.

Drugs·2026

Sarcolipin is a Conformation-Dependent Regulator of the Sarcoplasmic Reticulum Calcium Pump SERCA.

The Journal of membrane biology·2026

Scopolamine ameliorates psoriasis by blocking M1 receptor-mediated IL-23 production in dendritic cells.

Journal of immunology (Baltimore, Md. : 1950)·2026

[Buprenorphine and pain management: Clinical insights and practical landmarks].

Therapie·2026

Clinical Physiology of SGLT2 Inhibitors in Non-diabetic and Diabetic Individuals.

Handbook of experimental pharmacology·2026

Must RAAS-modifying drugs be withdrawn for the diagnosis of primary aldosteronism?

The Journal of clinical endocrinology and metabolism·2026

Phosphate storm in chronic kidney disease-mineral and bone disorder: practical clinical strategies for vascular calcification control.

Nephron·2026

Related Experiment Videos

Pharmacokinetic properties of the beta-adrenergic receptor blocking drugs

Related Concept Videos

Factors affecting free (unbound) lignocaine concentration in suspected acute myocardial infarction.

Effect of cetamolol on epinephrine-induced hypokalemia.

In support of cardiac chronotropic beta 2 adrenoceptors.

The effect of etodolac administration on renal function in patients with arthritis.

A free lignocaine index as a guide to unbound drug concentration.

Determinants of plasma alpha 1-acid glycoprotein (AAG) concentrations in health.

Antibiotic-Refractory Chronic Pouchitis After Ileal Pouch-Anal Anastomosis: Current and Emerging Therapeutic Strategies.

Current and Emerging Biomarkers and Surrogate Endpoints in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).

Doravirine/Islatravir: First Approval.

Anbenitamab: First Approval.

GLP-1 Receptor Agonists and Musculoskeletal Outcomes: A Systematic Literature Review and Meta-Analysis.

Safety Profile of the Non-steroidal Anti-inflammatory Drug Celecoxib in the Short-Term Management of Acute Non-cancer Pain: A Systematic Review with Meta-analysis of Randomised Controlled Trials.

Sarcolipin is a Conformation-Dependent Regulator of the Sarcoplasmic Reticulum Calcium Pump SERCA.

Scopolamine ameliorates psoriasis by blocking M1 receptor-mediated IL-23 production in dendritic cells.

[Buprenorphine and pain management: Clinical insights and practical landmarks].

Clinical Physiology of SGLT2 Inhibitors in Non-diabetic and Diabetic Individuals.

Must RAAS-modifying drugs be withdrawn for the diagnosis of primary aldosteronism?

Phosphate storm in chronic kidney disease-mineral and bone disorder: practical clinical strategies for vascular calcification control.

Related Experiment Videos

Pharmacokinetic properties of the beta-adrenergic receptor blocking drugs

Related Concept Videos

Related Articles